Navigation Links
Booster Dose for Chickenpox Vaccine Recommended

A study has been released by U.S scientists working for the Centers of Disease Control, Atlanta, that suggest immunity from chickenpox// conferred by Varicella vaccine may wane over the years, and even result in a more severe form of the disease. The study findings encourage a booster dose of the vaccine.

In the surveillance data, children vaccinated five or more years earlier were 2.6 times more likely to have a moderate-to-severe breakthrough case of chickenpox than those who had been vaccinated more recently.

Lead researcher Sandra S. Chaves and team have reported that the breakthrough varicella rate eight years after vaccination, was 12 times higher than in the first year after vaccination, even accounting for changes in exposure.

Findings were published in the New England Journal.

Says Chavez who came about the findings after following a sentinel population of 350, 000 subjects for 10 years after the implementation of universal varicella vaccination in 2005, “ Waning of immunity is of particular public health interest because it may result in increased susceptibility later in life, when the risk of severe complications may be greater than that in childhood."

Dr. Jane Seward, one of the authors of the study and an official at CDC, Atlanta, said that researchers decided to embark on the study after noticing outbreaks were happening despite vaccination programs.

Seward said the chickenpox vaccine provides 85 per cent protection, but of the remaining 15 per cent, most will get mild cases of chicken pox -- with a small number getting more severe illness.

It has been demonstrated that immunity from varicella vaccination wanes among health care workers in terms of measurable antibodies, but this is the first study to demonstrate that vaccination-induced immunity breaks down over time in children.
ANN
'"/>




Page: 1

Related medicine news :

1. Need for Hepatitis Booster Questioned
2. Booster dose not required for Hepatitis B Vaccination
3. Booster Dose Of Radiotherapy Beneficial In Early Breast Cancer
4. The Effectiveness Of Chickenpox Vaccine Questioned
5. Vaccine To Stop the Spread of Chickenpox
6. Maldives Volleyball Team Members Affected by Chickenpox
7. Vaccine to quit smoking?
8. First Vaccine Designed for Africa Cleared for Testing in Humans
9. Vaccine for Alzheimer’s diseas
10. Health Officials Recommend Flu Vaccine
11. Smallpox Vaccine May Help Fight Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and high ... to apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. The ... can receive up to $3,000. , The grant is named after California ...
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... thrilled to formally announce its Not a Moment to Lose fundraising campaign. As ... rally supporters dedicated to declaring victory over cancer. The campaign aims to raise ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 2016 , ... METTLER TOLEDO has launched its online ... papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user manuals, ... webinars and videos available online, visit the METTLER TOLEDO Expertise Library . ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Viking Therapeutics, ... clinical-stage biopharmaceutical company focused on the development of ... announced that the U.S. Food and Drug Administration ... for the treatment of X-linked adrenoleukodystrophy (X-ALD).  VK0214 ... (TRß) agonist that selectively regulates the expression of ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... of 340B (AIR 340B) projects the 340B Drug Pricing Program ... by which time it is expected to exceed $23 billion ... would see 340B purchases surpass current Medicare Part B drug ... The new study – based on analysis of data on ...
(Date:12/6/2016)... , Dec. 6, 2016  BioAtla, LLC, ... development of Conditionally Active Biologic (CAB) antibody ... Sinobioway Group Company, Limited (Sinobioway) selected their ... The specific program candidates and the targeted ... BioAtla and Sinobioway entered into a strategic ...
Breaking Medicine Technology: